-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HIBtOmmKTfmJ2c5dwRobI19qL2WumH7MmwGi71jyP3igS+GefeA84Vs3hY3OKhBl zD7oU6fv56ySRVYQtu69iA== 0001144204-07-039802.txt : 20070802 0001144204-07-039802.hdr.sgml : 20070802 20070802121756 ACCESSION NUMBER: 0001144204-07-039802 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070801 FILED AS OF DATE: 20070802 DATE AS OF CHANGE: 20070802 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 582-3950 MAIL ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABEL DOUGLAS CENTRAL INDEX KEY: 0001324106 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 071019267 BUSINESS ADDRESS: BUSINESS PHONE: 2125829847 MAIL ADDRESS: STREET 1: 787 SEVENTH AVENUE, 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 4 1 v082762_ex.xml X0202 4 2007-08-01 0 0001001316 MANHATTAN PHARMACEUTICALS INC MHA 0001324106 ABEL DOUGLAS 810 SEVENTH AVENUE NEW YORK NY 10019 1 1 0 0 Chief Executive Officer Common Stock 2007-08-01 4 A 0 10000 0.265 A 45000 I IRA Account /s/ Douglas Abel 2007-08-01 -----END PRIVACY-ENHANCED MESSAGE-----